주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판

Amadea Britton

AB

Amadea Britton

CDC/NCIRD, USA

Preliminary Talk Title: U.S. Experience with Respiratory Syncytial Virus (RSV) Prevention Product Introduction

Dr. Amadea Britton currently serves as a Medical Officer at the U.S. Centers for Disease Control and Prevention (CDC) where she works on the Vaccine Effectiveness and Policy Team in the Coronavirus and Other Respiratory Viruses Division. She is the Co-Lead of the U.S. Advisory Committee on Immunization Practices (ACIP) Work Group for RSV Vaccines in Adults and has contributed extensively to U.S. RSV vaccine policy development. Dr. Britton is a board-certified physician and completed Internal Medicine/Pediatrics clinical training at Duke University. She also holds a Master of Science from the Harvard T.H. Chan School of Public Health and is a former CDC Epidemic Intelligence Service Officer.